Calendar
event
Ex dividend date
10 Apr 2026
calendar_clock
Next Dividend Payment
14 May 2026
About Haleon plc
Ticker
info
HLN
Trading on
info
NYSE
ISIN
info
US4055521003
Industry
info
Drug Manufacturers - Specialty & Generic
Sector
info
Healthcare
CEO
info
Brian James McNamara
Headquarters
info
The Heights, Weybridge, undefined, United Kingdom, KT13 0NY
Employees
info
24,561
Website
info
haleon.com
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Metrics
BasicAdvanced
Market cap
info
$45.7B
P/E ratio
info
20.52
EPS
info
$0.50
Dividend Yield
info
0.69%
Beta
info
0.25
Forward P/E ratio
info
19.23
EBIDTA
info
$2.73B
Ex dividend date
info
2026-04-10
Price & volume
Market cap
info
$45.7B
Average daily volume
info
8.9M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.07
Dividend yield
info
0.69%
Forward dividend per share
info
$0.19
Forward dividend yield
info
1.85%
Payout ratio
info
51.43%
Valuation
P/E ratio
info
20.52
Forward P/E
info
19.23
PEG ratio
info
2.44
Trailing P/E
info
20.52
Price to sales
info
4.14
Price to book
info
2.09
Earnings
EPS
info
$0.50
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$2.73B
Revenues (TTM)
info
$11B
Revenues per share (TTM)
info
$2.46
Technicals
Beta
info
0.25
52-week High
info
$11.35
52-week Low
info
$8.71
50-day moving average
info
$10.49
200-day moving average
info
$9.96
Short ratio
info
2.47
Short %
info
0.42%
Management effectiveness
ROE (TTM)
info
10.27%
ROA (TTM)
info
4.65%
Profit margin
info
15.11%
Gross profit margin
info
$7.14B
Operating margin
info
22.92%
Growth
Quarterly earnings growth (YoY)
info
92.00%
Quarterly revenue growth (YoY)
info
0.60%
Share stats
Outstanding Shares
info
4.45B
Float
info
8.84B
Insiders %
info
0.01%
Institutions %
info
12.73%
Analyst Insights & forecasts
info

80% Buy

0% Hold

20% Sell

Based on information from 5 analysts.

Average price target

info
$11.93
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.13
-
-
Q1 • 25Beat
$0.09
$0.11
-15.57%
Q2 • 25Missed
$0.12
$0.13
-2.62%
Q3 • 25Missed
-
$0.11
-
Q4 • 25Beat
-
$0.12
-100.00%
Q1 • 26Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$5.48B
$806M
14.71%
Q2 • 25
$5.52B
$856M
15.51%
Q4 • 25
0.65%
6.17%
5.48%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$31.8B
$15.8B
49.74%
Q2 • 25
$32.6B
$16.1B
49.48%
Q4 • 25
2.34%
1.82%
-0.51%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$1.13B
-
$-2.79B
$1.03B
Q2 • 25
$1.48B
-
$-529M
$1.26B
Q4 • 25
31.43%
-
-81.02%
21.61%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Haleon plc share?
Collapse

Haleon plc shares are currently traded for undefined per share.

How many shares does Haleon plc have?
Collapse

Haleon plc currently has 4.45B shares.

Does Haleon plc pay dividends?
Collapse

Yes, Haleon plc does pay dividends.

What is Haleon plc 52 week high?
Collapse

Haleon plc 52 week high is $11.35.

What is Haleon plc 52 week low?
Collapse

Haleon plc 52 week low is $8.71.

What is the 200-day moving average of Haleon plc?
Collapse

Haleon plc 200-day moving average is $9.96.

Who is Haleon plc CEO?
Collapse

The CEO of Haleon plc is Brian James McNamara.

How many employees Haleon plc has?
Collapse

Haleon plc has 24,561 employees.

What is the market cap of Haleon plc?
Collapse

The market cap of Haleon plc is $45.7B.

What is the P/E of Haleon plc?
Collapse

The current P/E of Haleon plc is 20.52.

What is the EPS of Haleon plc?
Collapse

The EPS of Haleon plc is $0.50.

What is the PEG Ratio of Haleon plc?
Collapse

The PEG Ratio of Haleon plc is 2.44.

What do analysts say about Haleon plc?
Collapse

According to the analysts Haleon plc is considered a buy.